Zobrazeno 1 - 10
of 546
pro vyhledávání: '"H. Yoshikura"'
Publikováno v:
BioTechniques, Vol 29, Iss 1, Pp 38-42 (2000)
Externí odkaz:
https://doaj.org/article/34f4bcd7e365404fafd43fd26945845f
Publikováno v:
Archives of Virology. 142:139-149
Ecotropic murine leukemia viruses (MuLVs) are classified into B-N-, or NB-tropic MuLV by their host range determined by the Fv-1 gene product. B-tropic MuLV is restricted in N-type mouse cells (Fv-1 n/n) and N-tropic MuLV is restricted in B-type mous
Publikováno v:
Hepatology. 23:205-209
We previously demonstrated that a human T-cell line, HPBMa10-2 derived from HPBALL, was capable of supporting a productive infection of hepatitis C virus (HCV). We subsequently found Daudi cells, a human B-cell line, to be susceptible to HCV infectio
Publikováno v:
Journal of Viral Hepatitis. 3:3-10
SUMMARY. The mode of replication of the hepatitis C virus (HCV) remains poorly understood. Attempts to produce a tissue culture model containing replicating HCV have been largely unsuccessful. Recent studies on sera from patients chronically infected
Autor:
Y K, Shimizu, H, Yoshikura
Publikováno v:
Methods in molecular medicine. 19
In spite of the recent progress in molecular biology of the hepatitis C virus (HCV) genome, the biological characteristics of this virus remain poorly known. This is primarily because biological assays for HCV have been limitted to the experimental i
Autor:
H. Yoshikura
Publikováno v:
Digestive and Liver Disease. 33:449-451
Autor:
T. Ishiyama, S. Kobayakawa, Y. Hosaka, A. Totsuka, H. Yoshikura, M. Kaneda, Y. Yamamoto, S. Kamishikiryo, T. Kinoshita
Publikováno v:
36th AIAA Thermophysics Conference.
Hypersonic aerodynamic heating induced by the complex shock-shock interactions, has been investigated for a first stage winged reusable rocket combined with two rocket boosters. Hypersonic wind tunnel tests have been made by using NAL Mach 10 HWT and
Publikováno v:
Japanese journal of infectious diseases. 54(6)
Publikováno v:
BioTechniques. 31(4)
Publikováno v:
Japanese journal of infectious diseases. 54(2)